Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Randall W. Barton"'
Dual Effects of Nanoviricides Platform Technology Based NV-CoV-2 Biomimetic Polymer Against COVID-19
Autor:
Bethany Pond, Jay Tatake, Neelam Holkar, Anil Diwan, Vinod Arora, Vijetha Chiniga, Preetam Holkar, Ashok Chakraborty, Yogesh Thakur, Randall W. Barton
Remdesivir (RDV) is the only antiviral drug so far approved for COVID-19 therapy by the FDA. However its efficacy is limited in vivo due to its low stability in presence of plasma. This paper compared the stability of RDV encapsulated with our platfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ca65a8d5caea97f766b9ccc969ecc37
https://doi.org/10.1101/2021.11.24.469813
https://doi.org/10.1101/2021.11.24.469813
Autor:
Neelam Holkar, Tatake Jayant G, Randall W. Barton, Preetam Holkar, Ashok Chakraborty, Rajesh Pandey, Vijetha Chiniga, Anil Diwan, Vinod Arora
Human coronaviruses (HCoVs) cause respiratory diseases infecting the upper and/or lower respiratory tract. The six human coronaviruses so far identified are HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU-1, SARS-CoV, and MERS-CoV. Four of these coronaviru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b61c810d7433bd96bb14c9d04654a76c
https://doi.org/10.9734/bpi/rdmmr/v13/12399d
https://doi.org/10.9734/bpi/rdmmr/v13/12399d
Autor:
Preetam Holkar, Brian Friedrich, Neelam Holkar, Anil Diwan, Vinod Arora, Ashok Chakraborty, Vijetha Chiniga, Rajesh Pandey, Tatake Jayant G, Randall W. Barton
Publikováno v:
Integrative Molecular Medicine. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7e0d30e250cb3a6dd6de31488f6d95a
https://doi.org/10.15761/imm.1000407
https://doi.org/10.15761/imm.1000407
Autor:
Randall W. Barton, Daniel T. Larose, Guo Shen, Qian Wu, Kevin J. Felice, Charles H. Whitaker, Allan L. Metzger
Publikováno v:
Neuromuscular Disorders. 28:660-664
Sporadic inclusion body myositis (IBM) is the most common acquired myopathy affecting patients over age 50. The discovery of an autoantibody directed against a 43–44 kD protein (anti-cytosolic-5′-nucleotidase 1A or anti-cN1A) has provided support
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4bbf3c9061b16ea2236cff90aaa8a24
https://doi.org/10.1016/j.nmd.2018.06.005
https://doi.org/10.1016/j.nmd.2018.06.005
Publikováno v:
Connecticut medicine. 81(2)
Long-term acute care hospitals (LTACHs) have high rates of antibiotic and device use, hospital-acquired infections, and antibiotic resistance. Admission surveillance cultures are controversial.Evaluate the significance of patienthistory and multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da936249538452dd25c0e23ef1929a2f
https://pubmed.ncbi.nlm.nih.gov/29738150
https://pubmed.ncbi.nlm.nih.gov/29738150
Publikováno v:
The Journal of Vascular Access. 15:51-55
Purpose Patients at long-term acute care hospitals (LTACs) are medically complex with multiple comorbidities and high rates of antibiotic and device use. The objective of the study was to analyze the incidence and rate of central line-associated bloo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad8da844c7ee2e8df6479f8a7c288e36
https://doi.org/10.5301/jva.5000178
https://doi.org/10.5301/jva.5000178
Publikováno v:
Journal of Medical Economics. 14:141-146
Compare clinical outcomes and costs in a study group of long-term acute care hospital (LTCH) patients with a control group of LTCH-eligible patients in an acute care hospital. LTCHs were created to provide post-acute care services not available at ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a87984f1f798cb59690e5d38a85dc2c
https://doi.org/10.3111/13696998.2010.551163
https://doi.org/10.3111/13696998.2010.551163
Autor:
Simon C. Barry, Ofer Yanay, William R. A. Osborne, Lisa Y. Flint, Randall W. Barton, Margaret Brzezinski
Publikováno v:
Human Gene Therapy. 14:1587-1593
Recombinant erythropoietin (EPO) is widely administered for long-term treatment of anemia associated with renal failure and other chronic diseases. The ability to deliver EPO by gene therapy would have clinical and economic benefit. We compared autol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406049b8bbe8c7cf4ff70ba7def63494
https://doi.org/10.1089/104303403322542239
https://doi.org/10.1089/104303403322542239
Autor:
Gregory W. Peet, Randall W. Barton, Jun Li, Paul T. Massa, Kenneth B. Marcu, Darlene Balzarano, Xiang Li
Publikováno v:
Journal of Biological Chemistry. 276:18579-18590
The IkappaB kinase (IKK) signaling complex is responsible for activating NF-kappaB-dependent gene expression programs. Even though NF-kappaB-responsive genes are known to orchestrate stress-like responses, critical gaps in our knowledge remain about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9f52a35258fcc5719441f298b0c5c9
https://doi.org/10.1074/jbc.m100846200
https://doi.org/10.1074/jbc.m100846200
Publikováno v:
APOPTOSIS. 6:151-160
In the present investigations, we have shown differential cleavage of cellular PARP and a caspase 3-selective synthetic tetrapeptide substrate, Z-DEVD-AFC or Ac-DEVD-AMC using a T lymphoblastoid cell line Jurkat, and its variant clone E6.1(J-E6). Ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ad6944b7d18f7dc247a8df4ea26511d
https://doi.org/10.1023/a:1011375024832
https://doi.org/10.1023/a:1011375024832